#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Peter McWilliams Email
Chief Business Officer . Glycomine
How to contact Peter McWilliams
Join and see Peter's contact info for free!Current Roles
Employees:
24Revenue:
$1.9MAbout
Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding for which no other therapeutic options exist. The company's approach is to use replacement therapies – substrates, enzymes, or proteins – and to target those molecules to clinically relevant cellular compartments. Glycomine’s lead drug candidate, GLM101, is a novel substrate replacement therapy in development to treat phosphomannomutase 2-congenital disorder of glycosylation (PMM2-CDG), a rare disease representing a critical unmet medical need.Glycomine Address
733 Industrial RoadSan Carlos, CA